Method of administering a human ocular treating agent and product therefor
OwnerSidney Lermaninventor
Life of this patent
Estimating the term…
Abstract
A method of administering an agent to the ocular lens of animals for the treatment of an aging parameter and nuclear cataracts therein which includes the steps of preparing a solution of D,L-penicillamine; exposing an artificial ocular contact lens to the solution such that the compound is retained on the artificial lens; and contacting the animal lens with the artificial lens so that the compound is absorbed into the animals lens. Another method is to incorporate the compound in a timed-release carrying agent and place the agent in the inferior cul de sac of the eye.
Claims8
A method of administering an agent to animal ocular lenses for the treatment of nuclear cataracts therein, comprising the steps of:
- a. preparing a solution which is isotonic with animal tears and which includes physiological saline and an effective amount of said agent to form a saturated solution, said agent being D,L-penicillamine;
- b. exposing artificial ocular contact lenses to said solution for a sufficient period of time wherein said agent is retained on said lenses;
- and
- c. placing said exposed artificial lenses on the ocular cornea and/or cornea and sclera whereby said agent enters said ocular lenses.
A method of administering an agent to animal ocular lenses for the treatment of the formation of nuclear cataracts therein, comprising the steps of incorporating an effective amount of D,L-penicillamine in a sustained release carrier and placing said carrier within the inferior cul de sac of the eye.
An ocular lens treatment composition for animals, comprising an effective amount of D,L-penicillamine and a sustained release carrier therefor in a form for placement in the inferior cul de sac of the eye for the treatment of nuclear cataracts in said lens.
A method of treating nuclear sclerosis in animals comprising the step of administering to the ocular lens an effective amount of D,L-penicillamine.
Dependencies are inferred from the claim text.